Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AsiaMedicSGX:505 Days Payable is 379.20 as of Dec. 2025, which is 34% above its 10-year median of 282.56. The stock has 4 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, AsiaMedic ranks better than 89.47% on this metric.
AsiaMedic's average Accounts Payable for the
six
months ended in Dec. 2025 was S$2.26 Mil. AsiaMedic's Cost of Goods Sold for the
six
months ended in Dec. 2025 was S$1.09 Mil.
Hence, AsiaMedic's Days Payable for the
six
months ended in Dec. 2025 was 379.20.
The historical rank and industry rank for AsiaMedic's Days Payable or its related term are showing as below:
SGX:505'
s Days Payable Range Over the Past 10 Years
Min: 29.66 Med: 282.56 Max: 379.09
Current: 354.63
During the past 13 years, AsiaMedic's highest Days Payable was 379.09. The lowest was 29.66. And the median was 282.56.
SGX:505's Days Payable is ranked better than 89.47% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 64.795
vs SGX:505: 354.63
AsiaMedic's Days Payable
increased
from Dec. 2024 (315.68) to Dec. 2025 (379.20).
It may suggest that AsiaMedicdelayed paying its suppliers.
The historical data trend for AsiaMedic's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:505 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, AsiaMedic's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AsiaMedic Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, AsiaMedic's Days Payable distribution charts can be found below:
* The bar in red indicates where AsiaMedic's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
AsiaMedic's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AsiaMedic (SGX:505) has a Days Payable of 379.20 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on AsiaMedic and its competitors. This is 34% above median its historical median of 282.56. Over the past decade, AsiaMedic's Days Payable has ranged from 29.66 to 379.09. According to the industry distribution chart, AsiaMedic ranks #20 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 10.5%.
Is AsiaMedic's Days Payable too high?
AsiaMedic's current Days Payable of 379.20 is 34% above median its 10-year median of 282.56. Over the past 10 years, this metric has ranged from a low of 29.66 to a high of 379.09. The Medical Diagnostics & Research industry median Days Payable is 64.80. AsiaMedic's value of 379.20 is 485.2% above this industry median. Based on the distribution chart, AsiaMedic ranks #20 out of 190 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does AsiaMedic's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, AsiaMedic ranks #20 out of 190 companies for Days Payable. This places AsiaMedic in the top 11% of its industry — outperforming the majority of peers. The industry median Days Payable is 64.80. AsiaMedic's value of 379.20 is 485.2% above this benchmark. Historically, AsiaMedic's own Days Payable has ranged from 29.66 to 379.09 over the past decade. While the company's 10-year median is 282.56 vs. the industry median of 64.80, AsiaMedic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.80, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AsiaMedic's current Days Payable of 379.20 is 485.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on AsiaMedic and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AsiaMedic's current Days Payable is 379.20, which is 34% above median its own 10-year median of 282.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AsiaMedic stock overvalued right now?
Based on GuruFocus' analysis, AsiaMedic (SGX:505) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.02, compared to a current price of S$0.02 — trading 15% above its estimated fair value. The current Days Payable is 379.20, which is 34% above median its 10-year median of 282.56 and 485.2% above the Medical Diagnostics & Research industry median of 64.80. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For AsiaMedic (SGX:505), the current Days Payable is 379.20 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AsiaMedic Ltd is an investment holding company. The principal activities of the company include the provision of management services. It engaged in the business of operating medical clinics in Singapore. It generates revenue from health screening and medical wellness services, diagnostic imaging and radiology services, primary care services and sales of pharmaceutical products, and medical aesthetic services and related products, net of discounts.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:505 has been successfully added to your 
